
DCC-3116
CAS No. 2543673-19-2
DCC-3116( —— )
Catalog No. M37585 CAS No. 2543673-19-2
DCC-3116 is an orally active, selective and potent ULK1/2 inhibitor with anticancer activity.DCC-3116 inhibits autophagy and can be used in cancer research.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 296 | Get Quote |
![]() ![]() |
5MG | 459 | Get Quote |
![]() ![]() |
10MG | 657 | Get Quote |
![]() ![]() |
25MG | 994 | Get Quote |
![]() ![]() |
50MG | 1371 | Get Quote |
![]() ![]() |
100MG | 1773 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDCC-3116
-
NoteResearch use only, not for human use.
-
Brief DescriptionDCC-3116 is an orally active, selective and potent ULK1/2 inhibitor with anticancer activity.DCC-3116 inhibits autophagy and can be used in cancer research.
-
DescriptionDCC-3116 is an orally active, selective and potent ULK1/2 inhibitor with anticancer activity.DCC-3116 inhibits autophagy and can be used in cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy | Ras
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2543673-19-2
-
Formula Weight535.61
-
Molecular FormulaC26H36F3N7O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(CCOCC1)CCCNC2=NC(=NC=C2C(F)(F)F)NC3=CC=C(C=C3CC)N4CCN(C)CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Succinylsulfathiazol...
Succinylsulfathiazole is a sulfonamide, it is an ultra long acting drug.
-
Ammonium Chloride
Ammonium chloride acts as a small molecule autophagy inhibitor.Ammonium chloride is a pH-regulating, heteropolar compound that can cause intracellular alkalosis and metabolic acidosis, thereby affecting enzyme activity and influencing processes in biological systems.
-
CA77.1
CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD).